Skip to main content
Erschienen in: Internal and Emergency Medicine 3/2023

02.02.2023 | Im - Original

Clinical and organizational impact of the use of different cardiac troponin assays for the diagnosis of myocardial infarction without persistent elevation of the ST segment at presentation (NSTEMI) in 12 Italian emergency departments (EDs): the TROCAR study

verfasst von: Laura Camoni, Maria Elena Tosti, Angelo Maria Pezzullo, Marco Marchetti, Chiara Cadeddu

Erschienen in: Internal and Emergency Medicine | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

The management of acute chest pain is one of the challenges for emergency departments (EDs) worldwide. This study aims to provide insights into clinical and organizational aspects related to the use of different cardiac troponin tests for the diagnosis of NSTEMI. A prospective observational study was conducted among 12 Italian EDs. Eligible participants had chest pain of suspected cardiac origin and accessed EDs from January 2017 to March 2019. A 30-day follow-up was performed to gather information about the main cardiac outcomes. Tests validity and performance were assessed by computing sensitivity, specificity, positive and negative predictive values and area under the ROC curve. The independent association between adverse event end point at 30 days and type of troponin was evaluated by multiple logistic regression models, using odds ratio and 95% confidence interval. 2913 patients were included. Almost 72% were affected by comorbidities and most of them stayed in the EDs for more than 3 h, with significant differences among the different troponin assays. The results of follow-up at 30 days for the outcomes considered for the patients who were ruled out in 3 h or less did not differ significantly compared to those ruled out after 3 h or more. After adjustment for confounders, patients admitted to an ED that used a high-sensitivity troponin were at a lower risk of having a MACE (OR = 0.53, 95%CI 0.35–0.90) and a non-significant lower risk of myocardial infarction (OR = 0.68, 95% CI 0.41–1.13, p = 0.1314) at 30 days compared to patients admitted to an ED that used a standard troponin. Appropriate troponin testing is extremely important for differential diagnosis and for addressing proper treatment and safe procedures for patients who are not admitted to the hospital.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
5.
Zurück zum Zitat Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease (GBD). Available from: GBD Results Tool | GHDx (healthdata.org) [Accessed 22 October 2022]. Institute for Health Metrics and Evaluation (IHME). Global Burden of Disease (GBD). Available from: GBD Results Tool | GHDx (healthdata.org) [Accessed 22 October 2022].
6.
Zurück zum Zitat Perugini E, Maggioni AP, Boccanelli A, Di Pasquale G (2010) Epidemiologia delle sindromi coronariche acute in Italia. G Ital Cardiol 11(10):718–729 Perugini E, Maggioni AP, Boccanelli A, Di Pasquale G (2010) Epidemiologia delle sindromi coronariche acute in Italia. G Ital Cardiol 11(10):718–729
9.
Zurück zum Zitat Collet JP, Thiele H, Barbato E et al (2021) 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). Eur Heart J 42(14):1289–1367. https://doi.org/10.1016/j.rec.2021.05.002CrossRefPubMed Collet JP, Thiele H, Barbato E et al (2021) 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European society of cardiology (ESC). Eur Heart J 42(14):1289–1367. https://​doi.​org/​10.​1016/​j.​rec.​2021.​05.​002CrossRefPubMed
12.
13.
Zurück zum Zitat Kavsak J, OrdonezLianos FSA (2018) Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the academy of the American association for clinical chemistry and the task force on clinical applications of cardiac bio-markers of the international federation of clinical chemistry and laboratory medicine. Clin Chem 63:645–655. https://doi.org/10.1373/clinchem.2017.277186CrossRef Kavsak J, OrdonezLianos FSA (2018) Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the academy of the American association for clinical chemistry and the task force on clinical applications of cardiac bio-markers of the international federation of clinical chemistry and laboratory medicine. Clin Chem 63:645–655. https://​doi.​org/​10.​1373/​clinchem.​2017.​277186CrossRef
16.
Zurück zum Zitat NICE (National Institute for Health and Care Excellence) (2014). Myocardial infarction (acute): early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays). NICE diagnostics guidance 15. http://www.nice.org.uk/guidance/dg15 NICE (National Institute for Health and Care Excellence) (2014). Myocardial infarction (acute): early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays). NICE diagnostics guidance 15. http://​www.​nice.​org.​uk/​guidance/​dg15
23.
Zurück zum Zitat Clerico A, Ripoli A, Zaninotto M et al (2019) Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: a multi-center study. Clin Chim Acta 496:25–34. https://doi.org/10.1016/j.cca.2019.06.012CrossRefPubMed Clerico A, Ripoli A, Zaninotto M et al (2019) Head-to-head comparison of plasma cTnI concentration values measured with three high-sensitivity methods in a large Italian population of healthy volunteers and patients admitted to emergency department with acute coronary syndrome: a multi-center study. Clin Chim Acta 496:25–34. https://​doi.​org/​10.​1016/​j.​cca.​2019.​06.​012CrossRefPubMed
24.
Zurück zum Zitat Apple FS, Collins PO, Kavsak PA et al (2021) Getting cardiac troponin right: appraisal of the 2020 European society of cardiology guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation by the international federation of clinical chemistry and laboratory medicine committee on clinical applications of cardiac bio-markers. Clin Chem 67:730–735. https://doi.org/10.1093/clinchem/hvaa337CrossRefPubMed Apple FS, Collins PO, Kavsak PA et al (2021) Getting cardiac troponin right: appraisal of the 2020 European society of cardiology guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation by the international federation of clinical chemistry and laboratory medicine committee on clinical applications of cardiac bio-markers. Clin Chem 67:730–735. https://​doi.​org/​10.​1093/​clinchem/​hvaa337CrossRefPubMed
25.
Zurück zum Zitat Leo G, Lodi A, Tubertini P, Di Martino M (2016) Emergency department management in Lazio, Italy. Omega 58:28–138CrossRef Leo G, Lodi A, Tubertini P, Di Martino M (2016) Emergency department management in Lazio, Italy. Omega 58:28–138CrossRef
30.
Zurück zum Zitat National Institute for Health and Care Excellence (NICE). High-sensitivity troponin tests for the early rule out of NSTEMI. Diagnostics guidance 2020. Available from: www.nice.org.uk/guidance/dg40 [Accessed 2 May 2022]. National Institute for Health and Care Excellence (NICE). High-sensitivity troponin tests for the early rule out of NSTEMI. Diagnostics guidance 2020. Available from: www.​nice.​org.​uk/​guidance/​dg40 [Accessed 2 May 2022].
31.
Zurück zum Zitat Apple FS, Collinson PO, Kavsak PA et al (2021) Getting cardiac troponin right: appraisal of the 2020 European society of cardiology guidelines for the management of acute coronary syndromes in patients presenting without Persistent ST-segment elevation by the international federation of clinical chemistry and laboratory medicine committee on clinical applications of cardiac bio-markers. Clin Chem 67(5):730–735. https://doi.org/10.1093/clinchem/hvaa337CrossRefPubMed Apple FS, Collinson PO, Kavsak PA et al (2021) Getting cardiac troponin right: appraisal of the 2020 European society of cardiology guidelines for the management of acute coronary syndromes in patients presenting without Persistent ST-segment elevation by the international federation of clinical chemistry and laboratory medicine committee on clinical applications of cardiac bio-markers. Clin Chem 67(5):730–735. https://​doi.​org/​10.​1093/​clinchem/​hvaa337CrossRefPubMed
33.
Zurück zum Zitat START-ANTIPLATELET collaborators, Cesaro A, Gragnano F, Calabrò P, Moscarella E, Santelli F, Fimiani F, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Bossone E, Pengo V, Gresele P, Marcucci R (2021) Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the START-ANTIPLATELET registry. Int J Cardiol 345:7–13. https://doi.org/10.1016/j.ijcard.2021.10.138CrossRef START-ANTIPLATELET collaborators, Cesaro A, Gragnano F, Calabrò P, Moscarella E, Santelli F, Fimiani F, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Bossone E, Pengo V, Gresele P, Marcucci R (2021) Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: insights from the START-ANTIPLATELET registry. Int J Cardiol 345:7–13. https://​doi.​org/​10.​1016/​j.​ijcard.​2021.​10.​138CrossRef
Metadaten
Titel
Clinical and organizational impact of the use of different cardiac troponin assays for the diagnosis of myocardial infarction without persistent elevation of the ST segment at presentation (NSTEMI) in 12 Italian emergency departments (EDs): the TROCAR study
verfasst von
Laura Camoni
Maria Elena Tosti
Angelo Maria Pezzullo
Marco Marchetti
Chiara Cadeddu
Publikationsdatum
02.02.2023
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 3/2023
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03169-5

Weitere Artikel der Ausgabe 3/2023

Internal and Emergency Medicine 3/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.